In a recently published review, a research team led by MedUni Vienna has highlighted a promising new approach to drug discovery. The focus is on the...

Emerging evidence suggests reduced plasma PPP2R5C levels may serve as an early indicator of Alzheimer’s disease before overt clinical symptoms...

Emerging evidence suggests reduced plasma PPP2R5C levels may serve as an early indicator of Alzheimer’s disease before overt clinical symptoms...

Stem cells from lost baby teeth (SHED) can treat cerebral palsy, improving motor and brain function even after symptoms appear. A potential new...

Alfa Cytology supports oncolytic bacterial therapy research with its one-stop development platform and in vivo pharmacodynamic evaluation laboratory....

Alfa Cytology supports oncolytic bacterial therapy research with its one-stop development platform and in vivo pharmacodynamic evaluation laboratory....

Mayo Clinic researchers have identified a drug-and-supplement combination therapy that is capable of reducing the harmful effects of senescent cells...

It’s widely known that breastfeeding impacts the health of both mother and child, but the underlying biology that leads to these effects has been...

On the occasion of Rare Disease Day, the Biofisika Institute (CSIC, EHU) presents the progress of a project aimed at understanding the molecular...

The new generation of Alzheimer's disease drugs - the first proven to change the course of the disease - typically extend independent living for...